The agreement began May 1 and runs through April 30, 2014, according to a Teleflex news release.
VasoNova recently received 510(k) clearance from the FDA to market the VPS peripherally inserted central catheter tip location technology as an alternative to chest x-ray or fluoroscopy in adult patients.
Read the news release about the expanded agreement with Amerinet by Teleflex.
Learn more about Amerinet.
More Articles Featuring Amerinet:
Amerinet, FrontPath Health Coalition Sign Agreement for Pharmacy Benefit Management Programs
Amerinet, JBC Labs Sign Agreement for Specialized Compounded Pharmaceutical Products
